Anne Helene Olsen
- Oncology top 2%
- Global Cancer Incidence and Screening 30
- Colorectal Cancer Screening and Detection 26
- Cancer Risks and Factors 16
- Pharmacy top 5%
- Obesity and Health Practices 3
- Cancer Research top 10%
-
- BRCA gene mutations in cancer 5
-
- Diabetes Treatment and Management 4
- Growth Hormone and Insulin-like Growth Factors 3
-
- Pharmacology and Obesity Treatment 3
- Co-authors
- Elsebeth LyngeSisse Helle NjorThue W. SchwartzIlse VejborgStephen W. DuffyMy von Euler‐ChelpinPeter SasieniDonald Maxwell Parkin
- Cited by
- OncologyPharmacyCancer Research
- Partner nations
- DenmarkUnited KingdomUnited States
In The Last Decade
Anne Helene Olsen
40 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 97
- Oncology 1.1k
- Pharmacy 64
- Cancer Research 192
- Epidemiology 215
- Pulmonary and Respiratory Medicine 170
Countries citing papers authored by Anne Helene Olsen
This map shows the geographic impact of Anne Helene Olsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Helene Olsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Helene Olsen more than expected).
Fields of papers citing papers by Anne Helene Olsen
This network shows the impact of papers produced by Anne Helene Olsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Helene Olsen. The network helps show where Anne Helene Olsen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Anne Helene Olsen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 4 | |
| 3 | 2022 | 3 | |
| 4 | 2022 | 8 | |
| 5 | Weight loss and risk reduction of obesity-related outcomes in 0.5 million people: evidence from a UK primary care databasebreakdown → | 2021 | 119 |
| 6 | 2018 | 16 | |
| 7 | 2012 | 39 | |
| 8 | 2011 | 38 | |
| 9 | 2009 | 79 | |
| 10 | 2008 | 66 | |
| 11 | 2008 | 20 | |
| 12 | 2008 | 53 | |
| 13 | 2006 | 25 | |
| 14 | 2005 | 141 | |
| 15 | 2005 | 11 | |
| 16 | Mammography screening in the county of Fyn. November 1993-December 1999. | 2003 | 37 |
| 17 | 2003 | 60 | |
| 18 | 2003 | 37 | |
| 19 | [Mammography screening in the county of Copenhagen. Results of the first three screening rounds]. | 2002 | 6 |
| 20 | [Mammographic screening in the county of Copenhagen. Clinical consequences of the first three screening rounds]. | 2002 | 1 |
About Anne Helene Olsen
Anne Helene Olsen is a scholar working on Oncology, Pharmacy and Endocrinology, Diabetes and Metabolism, having authored 41 papers that have together received 1.5k indexed citations. Recurring topics across this work include Global Cancer Incidence and Screening (30 papers), Colorectal Cancer Screening and Detection (26 papers), Cancer Risks and Factors (16 papers), BRCA gene mutations in cancer (5 papers), Diabetes Treatment and Management (4 papers), Pharmacology and Obesity Treatment (3 papers), Growth Hormone and Insulin-like Growth Factors (3 papers) and Obesity and Health Practices (3 papers). The work is most often cited by research in Oncology (1.1k citations), Pharmacy (64 citations) and Cancer Research (192 citations). Anne Helene Olsen has collaborated with scholars based in Denmark, United Kingdom and United States. Frequent co-authors include Elsebeth Lynge, Sisse Helle Njor, Thue W. Schwartz, Ilse Vejborg, Stephen W. Duffy, Ilse Vejborg, My von Euler‐Chelpin, Peter Sasieni, Donald Maxwell Parkin and M Blichert-Toft. Their work appears in journals such as Cancer, BMJ and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.